EMG
PHAS

ETF Managers Group’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

ETF Managers Group’s Portfolio PHAS Stock Details PHAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-14,587
Closed -$21K – 864
2022
Q1 		$21K Buy
14,587
+51
+0.4% +$83 ﹤0.01% 686
2021
Q4 		$38K Sell
14,536
-2,636
-15% -$7.97K ﹤0.01% 673
2021
Q3 		$54K Buy
17,172
+2,993
+21% +$9.99K ﹤0.01% 654
2021
Q2 		$52K Buy
14,179
+5,184
+58% +$17.3K ﹤0.01% 635
2021
Q1 		$29K Sell
8,995
-5,288
-37% -$21.5K ﹤0.01% 657
2020
Q4 		$50K Sell
14,283
-2,151
-13% -$7.7K ﹤0.01% 612
2020
Q3 		$57K Buy
16,434
+7,779
+90% +$31.3K ﹤0.01% 610
2020
Q2 		$40K Buy
+8,655
New +$38.3K ﹤0.01% 593

Other funds holding PHAS

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.6B AUM 18.87% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return